Showing 681 - 700 results of 25,281 for search '(( 5 ((non decrease) OR (nn decrease)) ) OR ( 50 ((mg decrease) OR (a decrease)) ))', query time: 0.71s Refine Results
  1. 681
  2. 682
  3. 683
  4. 684
  5. 685
  6. 686

    Sequence of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

    Published 2024
    “…Transgenic <i>D</i>. <i>parva</i> showed a higher carotenoid content (3.18 mg/g DW) compared with control group (2.13 mg/g DW) at 9 d. …”
  7. 687

    Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

    Published 2024
    “…Transgenic <i>D</i>. <i>parva</i> showed a higher carotenoid content (3.18 mg/g DW) compared with control group (2.13 mg/g DW) at 9 d. …”
  8. 688
  9. 689
  10. 690

    Demonstrates that AS-IV mitigates the injury to the lungs and colon caused by LPS. by Cheng Luo (48047)

    Published 2024
    “…<p>(A) The therapeutic impact of AS-IV in decreasing the severity of lung pathology (Bar = 10μm and 50 μm). …”
  11. 691

    Adaptation of <i>B</i>. <i>subtilis</i> Rho<sup>+</sup> cells to a sudden nutrient downshift. by Vladimir Bidnenko (4258573)

    Published 2023
    “…Isogenic WT, (p)ppGpp<sup>0</sup> and Rho<sup>+</sup> strains were grown in liquid defined SM medium containing 0.5% (w/v) of CAA and spotted in serial dilutions on SM agar plates supplemented either with 0.5% (w/v) of CAA or with 0.05mg/ml of each of the eight amino acids (valine, isoleucine, leucine, threonine, histidine, arginine, tryptophan and methionine). …”
  12. 692
  13. 693
  14. 694

    Image_1_IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.TIF by Renée H. Fiechter (10230473)

    Published 2021
    “…</p><p>Objectives: To investigate the cellular and molecular pathways affected by IL-12p40/IL-23p40 blockade with ustekinumab in the synovium of PsA patients.</p><p>Methods: Eleven PsA patients with at least one inflamed knee or ankle joint were included in a 24-week single-center open-label study and received ustekinumab 45 mg/sc according to standard care at week 0, 4, and 16. …”
  15. 695
  16. 696

    Machine learning models and univariate analyses discriminating non-severe and severe COVID-19 patients. by Gamalat A. Elgedawy (18700038)

    Published 2024
    “…</b> Proximity plot of the RF model discriminating non-sever from severe COVID-19 patients. The ellipse shows confidence intervals <b>B.…”
  17. 697
  18. 698

    Assessment of indicators of vitamin A status in non-cirrhotic chronic hepatitis C patients by R.C. Santana (6516497)

    Published 2019
    “…Furthermore, more advanced stages of liver fibrosis were related to a decrease in serum vitamin A levels.</p></div>…”
  19. 699

    S5 Fig - by Cynthia Alsayyah (18452506)

    Published 2024
    “…Note the significant decrease in tubular mitochondria upon inactivation of <i>CTP1</i> in all conditions, including TEF-<i>OLE1</i>. …”
  20. 700